STA
RGEN icon

Summit Trail Advisors’s Repligen RGEN Stock Holding History

Summit Trail Advisors’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Sell
10,695
-778
-7% -$95.6K 0.02% 805
2026
Q1 		$1.35M Buy
11,473
+3,811
+50% +$532K 0.02% 786
2025
Q4 		$1.26M Buy
7,662
+388
+5% +$60.8K 0.02% 683
2025
Q3 		$972K Buy
7,274
+3,851
+113% +$468K 0.01% 852
2025
Q2 		$426K Buy
+3,423
New +$436K 0.01% 791

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Summit Trail Advisors's RGEN Position: Q2 2026 in Review

Summit Trail Advisors reduced its Repligen (RGEN) stake by 6.8% in Q2 2026, selling an estimated $95.6K and leaving 10,695 shares worth $1.46M. The position accounts for 0.02% of the portfolio, ranked #805.

Summit Trail Advisors first reported a position in RGEN in Q2 2025 and has held it in 5 quarters since. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Summit Trail Advisors held 10,695 shares of Repligen worth $1.46M as of Q2 2026.
  • Summit Trail Advisors sold 778 Repligen shares in Q2 2026, an estimated $95.6K.
  • Repligen made up 0.02% of Summit Trail Advisors's portfolio in Q2 2026, its #805 holding.
  • Summit Trail Advisors first reported a position in Repligen in Q2 2025 and has held it in 5 quarters since.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.